Rare diseases
Investigational molecules
Locations
Back to Bulgaria111 clinical trials in Haskovo, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
BulgariaStudy of Three Doses of Frevecitinib (KN-002) in Adults with Severe Asthma Not Controlled by Medium‑to‑High Dose Inhaled Steroid/LABA Therapy
BulgariaEfficacy and safety of oral semaglutide for weight loss in adults with overweight or obesity
BulgariaPhase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis
BulgariaRandomized trial of elecoglipron with dapagliflozin versus placebo in adults with type 2 diabetes mellitus and impaired renal function
BulgariaEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
BulgariaPhase 3 Study of Enpatoran in Patients with Active Cutaneous Lupus Erythematosus (with or without Systemic Disease)
BulgariaPumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation
BulgariaVMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk
BulgariaNipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus
BulgariaGB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents
BulgariaA study to assess the safety and effectiveness of GXV813 in hospitalized adults with schizophrenia
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Studies focusing on cardiovascular health and prevention, including trials evaluating new treatments for heart failure and atherosclerotic disease. Research emphasizes preventive measures and therapeutic interventions.
Multiple innovative therapies being tested to reduce cardiovascular events and improve patient outcomes.
Comprehensive research into respiratory conditions, with particular emphasis on COPD and asthma management. Studies evaluate both single and combination therapies.
Focus on improving lung function and reducing disease exacerbations through novel therapeutic approaches.
Investigation of treatments for various autoimmune conditions, including lupus, rheumatoid arthritis, and psoriasis. Research aims to develop targeted therapies.
Studies evaluate long-term safety and efficacy of new biological treatments.
Advanced research in cancer treatment, particularly focusing on breast cancer and various solid tumors. Studies include both single-agent and combination therapies.
Innovative approaches in targeting specific cancer pathways and managing treatment side effects.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
